BWX Technologies to Manufacture Cancer Treatment for Boston Scientific
07:57 AM EDT, 05/10/2021 (MT Newswires) -- BWX Medical (BWXT) said Monday it has signed a long-term, mutually exclusive agreement to manufacture TheraSphere Y-90 glass microspheres for Boston Scientific (BSX).
BWXT Medical is a subsidiary of BWX Technologies and a global supplier of medical isotopes and radiopharmaceuticals.
Under the terms of the agreement, BWXT Medical will automate the production process of its Ottawa facility to boost the production capacity of TheraSphere.
Developed for the treatment of liver cancer, TheraSphere contains millions of glass microspheres with radioactive Yttrium-90, which are delivered directly to liver tumors via the catheter resulting in minimal exposure to surrounding healthy tissue, the company said.
Financial terms were not disclosed.
Price: 66.00, Change: +0.62, Percent Change: +0.95